Evidence – Exploring the CombiCell Platform to Provides a Clinically Relevant Antigen-Biology Layer for Immunotherapy Discovery
Tumour Models London Summit 2026 · 2 December 2026 · 16:20
Evidence – Exploring the CombiCell Platform to Provides a Clinically Relevant Antigen-Biology Layer for Immunotherapy Discovery was a session at Tumour Models London Summit 2026 on 2 December 2026 in London, with 1 speaker on record.
Speakers
- Phil Jakeman — Speaker Chief Executive Officer, Matchbio